25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ABEO (Abeona Therapeutics Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Abeona Therapeutics Inc together

I guess you are interested in Abeona Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Abeona Therapeutics Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Abeona Therapeutics Inc’s Price Targets

I'm going to help you getting a better view of Abeona Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Abeona Therapeutics Inc

I send you an email if I find something interesting about Abeona Therapeutics Inc.

1. Quick Overview

1.1. Quick analysis of Abeona Therapeutics Inc (30 sec.)










1.2. What can you expect buying and holding a share of Abeona Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.81
Expected worth in 1 year
$1.79
How sure are you?
25.0%

+ What do you gain per year?

Total Gains per Share
$0.98
Return On Investment
16.6%

For what price can you sell your share?

Current Price per Share
$5.92
Expected price per share
$4.87 - $6.84
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Abeona Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)
$5.92
Intrinsic Value Per Share
$-12.68 - $-12.89
Total Value Per Share
$-11.87 - $-12.08

2.2. Growth of Abeona Therapeutics Inc (5 min.)




Is Abeona Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$41.3m$9.3m$41.7m81.7%

How much money is Abeona Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$11m-$19.1m$8.1m73.5%
Net Profit Margin0.0%-265.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Abeona Therapeutics Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#434 / 872

Most Revenue
#856 / 872

Most Profit
#543 / 872

Most Efficient
#255 / 872
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Abeona Therapeutics Inc?

Welcome investor! Abeona Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Abeona Therapeutics Inc.

First you should know what it really means to hold a share of Abeona Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Abeona Therapeutics Inc is $5.92. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Abeona Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Abeona Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.81. Based on the TTM, the Book Value Change Per Share is $0.25 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.13 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Abeona Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.24-4.0%-0.22-3.6%-0.37-6.3%-0.27-4.6%-0.30-5.1%-0.27-4.6%
Usd Book Value Change Per Share-0.05-0.9%0.254.2%-0.13-2.3%0.020.3%-0.09-1.5%0.020.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.05-0.9%0.254.2%-0.13-2.3%0.020.3%-0.09-1.5%0.020.3%
Usd Price Per Share4.76-5.22-5.13-4.21-3.06-5.10-
Price to Earnings Ratio-5.06--2.02--3.61--2.76--2.21--7.21-
Price-to-Total Gains Ratio-92.41--66.29--14.04--29.97--21.13--11.25-
Price to Book Ratio5.88-5.60-1.84-4.50-3.00-3.17-
Price-to-Total Gains Ratio-92.41--66.29--14.04--29.97--21.13--11.25-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.92
Number of shares168
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.25-0.09
Usd Total Gains Per Share0.25-0.09
Gains per Quarter (168 shares)41.28-14.94
Gains per Year (168 shares)165.11-59.76
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101651550-60-70
203303200-120-130
304954850-179-190
406606500-239-250
508268150-299-310
609919800-359-370
70115611450-418-430
80132113100-478-490
90148614750-538-550
100165116400-598-610

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%1.019.00.05.0%1.039.00.02.5%10.0108.00.08.5%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%3.017.00.015.0%10.030.00.025.0%31.086.01.026.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%17.00.0101.014.4%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%3.017.00.015.0%10.030.00.025.0%37.080.01.031.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Abeona Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0520.246-121%-0.135+162%0.016-418%-0.089+73%0.019-376%
Book Value Per Share--0.8090.999-19%0.182+344%0.526+54%0.971-17%1.552-48%
Current Ratio--4.9006.143-20%5.309-8%5.220-6%4.188+17%8.036-39%
Debt To Asset Ratio--0.5830.563+4%0.845-31%0.668-13%0.540+8%0.349+67%
Debt To Equity Ratio--1.4001.335+5%2.511-44%1.781-21%1.288+9%0.746+88%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--269692892.000306199133.750-12%258167337.500+4%228015364.717+18%178090186.525+51%297736753.763-9%
Eps---0.235-0.216-8%-0.375+59%-0.274+17%-0.303+29%-0.270+15%
Ev To Ebitda Ratio---6.600-3.204-51%-3.831-42%55.703-112%32.348-120%9.122-172%
Free Cash Flow Per Share---0.387-0.308-20%-0.199-49%-0.239-38%-0.247-36%-0.215-44%
Free Cash Flow To Equity Per Share---0.2550.109-333%0.107-339%0.072-454%-0.038-85%17.484-101%
Gross Profit Margin--1.0001.019-2%1.043-4%1.029-3%1.017-2%1.011-1%
Intrinsic Value_10Y_max---12.886----------
Intrinsic Value_10Y_min---12.675----------
Intrinsic Value_1Y_max---0.923----------
Intrinsic Value_1Y_min---1.017----------
Intrinsic Value_3Y_max---3.055----------
Intrinsic Value_3Y_min---3.293----------
Intrinsic Value_5Y_max---5.524----------
Intrinsic Value_5Y_min---5.811----------
Market Cap302847664.000+20%243505892.000267240383.750-9%262178087.500-7%215471281.383+13%156695086.525+55%260721178.763-7%
Net Profit Margin----0%-2.6580%-13.7680%-12.8070%-14.5120%
Operating Margin----0%-2.6410%-13.7440%-12.6860%-14.5670%
Operating Ratio----0%2.184-100%31.125-100%22.135-100%27.284-100%
Pb Ratio7.316+20%5.8825.596+5%1.840+220%4.496+31%3.001+96%3.169+86%
Pe Ratio-6.294-24%-5.061-2.016-60%-3.611-29%-2.763-45%-2.211-56%-7.208+42%
Price Per Share5.920+20%4.7605.223-9%5.125-7%4.212+13%3.063+55%5.096-7%
Price To Free Cash Flow Ratio-3.823-24%-3.074-4.418+44%-6.820+122%-4.730+54%-3.954+29%-9.320+203%
Price To Total Gains Ratio-114.933-24%-92.412-66.288-28%-14.040-85%-29.969-68%-21.132-77%-11.253-88%
Quick Ratio--8.56310.701-20%9.076-6%8.854-3%6.910+24%10.005-14%
Return On Assets---0.121-0.101-17%-0.293+142%-0.175+44%-0.180+49%-0.133+10%
Return On Equity---0.291-0.265-9%-0.860+196%-0.487+68%-0.421+45%-0.264-9%
Total Gains Per Share---0.0520.246-121%-0.135+162%0.016-418%-0.089+73%0.019-376%
Usd Book Value--41396000.00051110250.000-19%9332000.000+344%26897416.667+54%49675800.000-17%79374000.000-48%
Usd Book Value Change Per Share---0.0520.246-121%-0.135+162%0.016-418%-0.089+73%0.019-376%
Usd Book Value Per Share--0.8090.999-19%0.182+344%0.526+54%0.971-17%1.552-48%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--269692892.000306199133.750-12%258167337.500+4%228015364.717+18%178090186.525+51%297736753.763-9%
Usd Eps---0.235-0.216-8%-0.375+59%-0.274+17%-0.303+29%-0.270+15%
Usd Free Cash Flow---19803000.000-15750250.000-20%-10160250.000-49%-12242833.333-38%-12658200.000-36%-10992375.000-44%
Usd Free Cash Flow Per Share---0.387-0.308-20%-0.199-49%-0.239-38%-0.247-36%-0.215-44%
Usd Free Cash Flow To Equity Per Share---0.2550.109-333%0.107-339%0.072-454%-0.038-85%17.484-101%
Usd Market Cap302847664.000+20%243505892.000267240383.750-9%262178087.500-7%215471281.383+13%156695086.525+55%260721178.763-7%
Usd Price Per Share5.920+20%4.7605.223-9%5.125-7%4.212+13%3.063+55%5.096-7%
Usd Profit---12029000.000-11046250.000-8%-19164750.000+59%-12054833.333+0%-14385650.000+20%-13198325.000+10%
Usd Revenue----0%1581000.000-100%621666.667-100%1190300.000-100%614350.000-100%
Usd Total Gains Per Share---0.0520.246-121%-0.135+162%0.016-418%-0.089+73%0.019-376%
 EOD+5 -3MRQTTM+2 -31YOY+19 -163Y+17 -185Y+18 -1710Y+6 -29

3.3 Fundamental Score

Let's check the fundamental score of Abeona Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.294
Price to Book Ratio (EOD)Between0-17.316
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than18.563
Current Ratio (MRQ)Greater than14.900
Debt to Asset Ratio (MRQ)Less than10.583
Debt to Equity Ratio (MRQ)Less than11.400
Return on Equity (MRQ)Greater than0.15-0.291
Return on Assets (MRQ)Greater than0.05-0.121
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Abeona Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.397
Ma 20Greater thanMa 505.863
Ma 50Greater thanMa 1006.033
Ma 100Greater thanMa 2005.574
OpenGreater thanClose5.710
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Abeona Therapeutics Inc

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is pz-cel, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.

Fundamental data was last updated by Penke on 2025-07-09 05:05:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Abeona Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Abeona Therapeutics Inc to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Abeona Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-265.8%+265.8%
TTM-5Y-1,280.7%+1,280.7%
5Y-1,280.7%10Y-1,451.2%+170.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--91.7%+91.7%
TTM--140.3%+140.3%
YOY-265.8%-196.4%-69.4%
3Y-1,376.8%-247.9%-1,128.9%
5Y-1,280.7%-343.3%-937.4%
10Y-1,451.2%-488.1%-963.1%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Abeona Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Abeona Therapeutics Inc to theΒ Biotechnology industry mean.
  • -12.1% Return on Assets means thatΒ Abeona Therapeutics Inc generatedΒ $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Abeona Therapeutics Inc:

  • The MRQ is -12.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.1%TTM-10.1%-2.1%
TTM-10.1%YOY-29.3%+19.2%
TTM-10.1%5Y-18.0%+8.0%
5Y-18.0%10Y-13.3%-4.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.1%-11.5%-0.6%
TTM-10.1%-11.5%+1.4%
YOY-29.3%-11.4%-17.9%
3Y-17.5%-11.7%-5.8%
5Y-18.0%-11.9%-6.1%
10Y-13.3%-13.7%+0.4%
4.3.1.3. Return on Equity

Shows how efficient Abeona Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Abeona Therapeutics Inc to theΒ Biotechnology industry mean.
  • -29.1% Return on Equity means Abeona Therapeutics Inc generated $-0.29Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Abeona Therapeutics Inc:

  • The MRQ is -29.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -26.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-29.1%TTM-26.5%-2.5%
TTM-26.5%YOY-86.0%+59.4%
TTM-26.5%5Y-42.1%+15.5%
5Y-42.1%10Y-26.4%-15.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.1%-13.6%-15.5%
TTM-26.5%-14.8%-11.7%
YOY-86.0%-14.4%-71.6%
3Y-48.7%-16.8%-31.9%
5Y-42.1%-17.5%-24.6%
10Y-26.4%-19.5%-6.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Abeona Therapeutics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Abeona Therapeutics Inc is operatingΒ .

  • Measures how much profit Abeona Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Abeona Therapeutics Inc to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Abeona Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-264.1%+264.1%
TTM-5Y-1,268.6%+1,268.6%
5Y-1,268.6%10Y-1,456.7%+188.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--221.8%+221.8%
TTM--250.7%+250.7%
YOY-264.1%-208.5%-55.6%
3Y-1,374.4%-220.2%-1,154.2%
5Y-1,268.6%-342.4%-926.2%
10Y-1,456.7%-462.5%-994.2%
4.3.2.2. Operating Ratio

Measures how efficient Abeona Therapeutics Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Abeona Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY2.184-2.184
TTM-5Y22.135-22.135
5Y22.13510Y27.284-5.150
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.097-2.097
TTM-2.684-2.684
YOY2.1843.076-0.892
3Y31.1253.524+27.601
5Y22.1354.724+17.411
10Y27.2846.445+20.839
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Abeona Therapeutics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Abeona Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 4.90Β means the company has $4.90 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Abeona Therapeutics Inc:

  • The MRQ is 4.900. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.143. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.900TTM6.143-1.243
TTM6.143YOY5.309+0.833
TTM6.1435Y4.188+1.955
5Y4.18810Y8.036-3.849
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9003.638+1.262
TTM6.1433.846+2.297
YOY5.3094.140+1.169
3Y5.2204.688+0.532
5Y4.1885.722-1.534
10Y8.0366.144+1.892
4.4.3.2. Quick Ratio

Measures if Abeona Therapeutics Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Abeona Therapeutics Inc to theΒ Biotechnology industry mean.
  • A Quick Ratio of 8.56Β means the company can pay off $8.56 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Abeona Therapeutics Inc:

  • The MRQ is 8.563. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 10.701. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.563TTM10.701-2.138
TTM10.701YOY9.076+1.625
TTM10.7015Y6.910+3.791
5Y6.91010Y10.005-3.095
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.5632.826+5.737
TTM10.7013.116+7.585
YOY9.0763.786+5.290
3Y8.8544.311+4.543
5Y6.9105.702+1.208
10Y10.0056.335+3.670
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Abeona Therapeutics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Abeona Therapeutics IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Abeona Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.58Β means that Abeona Therapeutics Inc assets areΒ financed with 58.3% credit (debt) and the remaining percentage (100% - 58.3%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Abeona Therapeutics Inc:

  • The MRQ is 0.583. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.563. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.583TTM0.563+0.020
TTM0.563YOY0.845-0.282
TTM0.5635Y0.540+0.023
5Y0.54010Y0.349+0.191
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5830.327+0.256
TTM0.5630.349+0.214
YOY0.8450.332+0.513
3Y0.6680.340+0.328
5Y0.5400.346+0.194
10Y0.3490.378-0.029
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Abeona Therapeutics Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Abeona Therapeutics Inc to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 140.0% means that company has $1.40 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Abeona Therapeutics Inc:

  • The MRQ is 1.400. The company is able to pay all its debts with equity. +1
  • The TTM is 1.335. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.400TTM1.335+0.066
TTM1.335YOY2.511-1.177
TTM1.3355Y1.288+0.046
5Y1.28810Y0.746+0.543
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4000.383+1.017
TTM1.3350.438+0.897
YOY2.5110.414+2.097
3Y1.7810.450+1.331
5Y1.2880.457+0.831
10Y0.7460.512+0.234
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Abeona Therapeutics Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Abeona Therapeutics Inc to theΒ Biotechnology industry mean.
  • A PE ratio of -5.06 means the investor is paying $-5.06Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Abeona Therapeutics Inc:

  • The EOD is -6.294. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.061. Based on the earnings, the company is expensive. -2
  • The TTM is -2.016. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.294MRQ-5.061-1.233
MRQ-5.061TTM-2.016-3.045
TTM-2.016YOY-3.611+1.594
TTM-2.0165Y-2.211+0.195
5Y-2.21110Y-7.208+4.997
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.294-2.399-3.895
MRQ-5.061-2.092-2.969
TTM-2.016-2.625+0.609
YOY-3.611-3.784+0.173
3Y-2.763-3.762+0.999
5Y-2.211-6.363+4.152
10Y-7.208-7.055-0.153
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Abeona Therapeutics Inc:

  • The EOD is -3.823. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.074. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.418. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.823MRQ-3.074-0.749
MRQ-3.074TTM-4.418+1.344
TTM-4.418YOY-6.820+2.402
TTM-4.4185Y-3.954-0.464
5Y-3.95410Y-9.320+5.366
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.823-3.299-0.524
MRQ-3.074-2.742-0.332
TTM-4.418-3.801-0.617
YOY-6.820-4.402-2.418
3Y-4.730-5.140+0.410
5Y-3.954-8.483+4.529
10Y-9.320-9.296-0.024
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Abeona Therapeutics Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 5.88 means the investor is paying $5.88Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Abeona Therapeutics Inc:

  • The EOD is 7.316. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.882. Based on the equity, the company is overpriced. -1
  • The TTM is 5.596. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD7.316MRQ5.882+1.434
MRQ5.882TTM5.596+0.287
TTM5.596YOY1.840+3.756
TTM5.5965Y3.001+2.595
5Y3.00110Y3.169-0.168
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD7.3162.113+5.203
MRQ5.8821.856+4.026
TTM5.5962.125+3.471
YOY1.8402.454-0.614
3Y4.4962.492+2.004
5Y3.0013.668-0.667
10Y3.1694.364-1.195
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Abeona Therapeutics Inc.

4.8.1. Institutions holding Abeona Therapeutics Inc

Institutions are holding 63.356% of the shares of Abeona Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Suvretta Capital Management, LLC7.20430.651368550300
2025-03-31Nantahala Capital Management, LLC6.8610.66383509850-19364-0.5487
2025-03-31Adage Capital Partners Gp LLC5.26150.02372691628-1210732-31.0256
2025-03-31Western Standard LLC4.45926.385222811991967819.4406
2025-03-31Vanguard Group Inc3.9490.00022020185541622.7549
2025-03-31Vivo Capital, LLC3.60221.1617184275100
2025-03-31Rosalind Advisors, Inc.3.534.1818058174270.0237
2025-03-31LAURION CAPITAL MANAGEMENT LP2.55410.1565130658900
2025-03-31Millennium Management LLC1.58330.0021809966-1307203-61.743
2025-03-31Susquehanna International Group, LLP1.48770.000676106818287431.6285
2025-03-31683 Capital Management LLC1.31950.2216675000-116845-14.756
2025-03-31Propel Bio Management LLC1.21983.45162402200
2025-03-31Kennedy Capital Management Inc1.21540.07076217636217630
2025-03-31Ikarian Capital, LLC1.0430.31353358100
2025-03-31Citigroup Inc1.03130.0013527558-86163-14.0394
2025-03-31BlackRock Inc1.01160.000151747961971.2121
2025-03-31Geode Capital Management, LLC0.94340.0002482619188924.0739
2025-03-31Newtyn Management LLC0.93830.361548000010000026.3158
2025-03-31Simplify Asset Management Inc.0.79870.072940858400
2025-03-31Marshall Wace Asset Management Ltd0.64980.002332400281072547.5998
Total 50.663117.719125917562-1278139-4.9%

4.9.2. Funds holding Abeona Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-05-31Vanguard Total Stock Mkt Idx Inv2.59110.00051325523455003.5546
2025-05-31Vanguard Institutional Extnd Mkt Idx Tr1.32550.003967809800
2025-05-31Simplify Propel Opportunities ETF1.09195.490455858410000021.8063
2025-03-31Kennedy Micro Cap0.96060.4934914314914310
2025-04-30Fidelity Extended Market Index0.44230.0041226253-2163-0.947
2025-05-31iShares Core S&P Total US Stock Mkt ETF0.21330.00110911200
2025-05-31IMC US Ultra Micro Cap0.20810.66881064421064420
2025-04-30Arctic Aurora LifeScience I0.18590.723395118951180
2025-03-31Extended Equity Market Fund K0.18580.0034950392910.3071
2025-03-31Kennedy Micro Cap Opportunities0.17160.477987809878090
2025-04-30Fidelity Total Market Index0.15990.00058180400
2025-05-31iShares Micro-Cap ETF0.15720.06478040400
2025-04-30Spartan Extended Market Index Pool F0.12810.0059655542094546.9524
2025-04-30Fidelity Series Total Market Index0.11370.00055818722464.0149
2025-03-31Northern Trust Extended Eq Market Idx0.0950.0034860900
2025-03-31NT Ext Equity Mkt Idx Fd - L0.0950.00294860900
2025-04-30Fidelity Nasdaq Composite Index0.08580.00174388300
2025-03-31Pleiades Small Cap Equity A0.08220.021642035420350
2025-03-31NT Ext Equity Mkt Idx Fd - NL0.07050.00293606900
2025-03-31Onelife Fund USD0.06180.6453161600
Total 8.42538.6154310179+989654+23.0%

5.3. Insider Transactions

Insiders are holding 6.138% of the shares of Abeona Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-06-06Brendan M O'malleySELL104706.76
2025-06-06Joseph Walter VazzanoSELL177956.76
2025-06-06Vishwas SeshadriSELL506766.76
2025-05-27Mark AlvinoSELL20006.38
2025-05-16Mark AlvinoSELL80005.68
2025-03-31Vishwas SeshadriSELL250004.78
2025-01-29Mark AlvinoSELL40005.38
2025-01-21Mark AlvinoSELL40005.1
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Other Current Liabilities  7,4832,2479,73040210,132-3,7356,397-7,211-814



5.2. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets99,364
Total Liabilities57,968
Total Stockholder Equity41,396
 As reported
Total Liabilities 57,968
Total Stockholder Equity+ 41,396
Total Assets = 99,364

Assets

Total Assets99,364
Total Current Assets88,121
Long-term Assets11,243
Total Current Assets
Cash And Cash Equivalents 15,936
Short-term Investments 68,219
Net Receivables 1,617
Other Current Assets 2,349
Total Current Assets  (as reported)88,121
Total Current Assets  (calculated)88,121
+/-0
Long-term Assets
Property Plant Equipment 11,186
Long-term Assets Other 57
Long-term Assets  (as reported)11,243
Long-term Assets  (calculated)11,243
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities17,983
Long-term Liabilities39,985
Total Stockholder Equity41,396
Total Current Liabilities
Short-term Debt 8,761
Short Long Term Debt 8,148
Accounts payable 5,018
Other Current Liabilities -814
Total Current Liabilities  (as reported)17,983
Total Current Liabilities  (calculated)21,113
+/- 3,130
Long-term Liabilities
Long term Debt 11,138
Capital Lease Obligations 4,691
Long-term Liabilities  (as reported)39,985
Long-term Liabilities  (calculated)15,829
+/- 24,156
Total Stockholder Equity
Common Stock490
Retained Earnings -825,287
Accumulated Other Comprehensive Income -67
Other Stockholders Equity 866,260
Total Stockholder Equity (as reported)41,396
Total Stockholder Equity (calculated)41,396
+/-0
Other
Capital Stock490
Cash and Short Term Investments 84,155
Common Stock Shares Outstanding 49,779
Liabilities and Stockholders Equity 99,364
Net Debt 8,041
Net Invested Capital 60,682
Net Working Capital 70,138
Property Plant and Equipment Gross 26,699
Short Long Term Debt Total 23,977



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-31
> Total Assets 
400
7,200
6,400
5,600
4,900
3,900
3,000
2,400
1,400
1,100
3,000
3,000
2,400
1,707
1,135
5,367
4,600
18,229
17,195
31,638
30,526
29,275
27,806
26,453
25,487
25,023
22,882
20,031
19,487
16,743
16,340
13,029
11,811
18,496
15,800
13,663
11,090
11,761
9,228
7,811
7,811
10,574
8,256
7,073
6,426
4,876
3,634
3,500
9,149
7,352
6,920
5,754
4,171
3,624
2,351
2,705
1,583
5,195
3,625
2,279
8,771
6,876
5,065
2,220
3,785
3,196
2,437
1,234
1,730
1,721
2,397
1,092
613
478
240
280
16,582
13,117
76,925
89,549
80,055
77,420
74,152
73,814
111,058
105,284
96,659
95,731
178,766
175,653
166,697
160,576
174,399
166,136
159,410
142,772
223,382
175,003
164,378
159,365
151,198
141,432
130,675
119,019
79,586
55,172
44,719
38,761
64,214
53,345
53,550
66,087
64,002
74,828
134,003
120,592
108,931
99,364
99,364108,931120,592134,00374,82864,00266,08753,55053,34564,21438,76144,71955,17279,586119,019130,675141,432151,198159,365164,378175,003223,382142,772159,410166,136174,399160,576166,697175,653178,76695,73196,659105,284111,05873,81474,15277,42080,05589,54976,92513,11716,5822802404786131,0922,3971,7211,7301,2342,4373,1963,7852,2205,0656,8768,7712,2793,6255,1951,5832,7052,3513,6244,1715,7546,9207,3529,1493,5003,6344,8766,4267,0738,25610,5747,8117,8119,22811,76111,09013,66315,80018,49611,81113,02916,34016,74319,48720,03122,88225,02325,48726,45327,80629,27530,52631,63817,19518,2294,6005,3671,1351,7072,4003,0003,0001,1001,4002,4003,0003,9004,9005,6006,4007,200400
   > Total Current Assets 
0
6,900
6,100
5,300
4,600
3,700
2,600
1,600
500
200
2,200
2,200
1,500
944
418
2,060
1,100
14,676
13,729
27,368
26,389
25,280
23,926
22,439
20,930
18,795
16,658
12,653
12,362
9,741
9,348
5,948
4,819
11,680
9,291
6,772
3,160
5,194
2,986
1,924
1,924
8,326
6,339
5,468
5,031
3,796
2,625
2,567
8,297
6,531
6,158
5,058
2,999
2,460
1,302
1,740
685
4,363
2,848
1,565
8,121
6,269
4,472
1,686
3,313
2,769
2,031
851
1,681
1,673
2,349
1,044
575
440
203
244
11,555
8,190
30,962
43,690
40,568
37,840
34,621
31,947
69,421
63,823
59,268
58,395
140,592
134,151
121,826
114,551
88,851
71,721
64,895
49,592
132,390
118,758
108,803
104,560
97,742
88,597
78,880
67,905
56,292
39,204
30,296
25,497
53,099
42,844
44,038
57,264
55,737
66,725
125,904
112,657
100,853
88,121
88,121100,853112,657125,90466,72555,73757,26444,03842,84453,09925,49730,29639,20456,29267,90578,88088,59797,742104,560108,803118,758132,39049,59264,89571,72188,851114,551121,826134,151140,59258,39559,26863,82369,42131,94734,62137,84040,56843,69030,9628,19011,5552442034405751,0442,3491,6731,6818512,0312,7693,3131,6864,4726,2698,1211,5652,8484,3636851,7401,3022,4602,9995,0586,1586,5318,2972,5672,6253,7965,0315,4686,3398,3261,9241,9242,9865,1943,1606,7729,29111,6804,8195,9489,3489,74112,36212,65316,65818,79520,93022,43923,92625,28026,38927,36813,72914,6761,1002,0604189441,5002,2002,2002005001,6002,6003,7004,6005,3006,1006,9000
       Cash And Cash Equivalents 
0
6,800
6,000
5,200
4,400
3,500
2,500
1,300
400
100
2,200
2,200
1,500
887
258
2,026
900
3,419
999
7,166
8,415
4,869
5,615
8,723
7,426
12,673
5,608
1,845
1,444
3,223
3,290
446
727
8,356
6,148
4,491
1,775
2,888
784
378
378
3,463
1,429
482
1,194
359
170
661
6,921
226
96
201
2,677
2,206
1,231
1,672
607
4,278
2,758
1,496
7,033
6,174
4,346
1,348
2,460
1,365
588
106
396
50
1,798
899
424
299
55
165
11,520
7,948
30,410
43,282
40,138
37,395
34,303
31,185
69,142
63,212
58,304
56,522
137,750
131,995
49,990
33,599
18,750
25,924
42,609
47,923
129,258
40,155
14,542
8,424
12,596
14,265
27,179
43,781
32,938
20,326
6,133
5,733
14,217
4,680
6,225
4,712
14,473
17,558
34,426
15,726
23,357
15,936
15,93623,35715,72634,42617,55814,4734,7126,2254,68014,2175,7336,13320,32632,93843,78127,17914,26512,5968,42414,54240,155129,25847,92342,60925,92418,75033,59949,990131,995137,75056,52258,30463,21269,14231,18534,30337,39540,13843,28230,4107,94811,520165552994248991,798503961065881,3652,4601,3484,3466,1747,0331,4962,7584,2786071,6721,2312,2062,677201962266,9216611703591,1944821,4293,4633783787842,8881,7754,4916,1488,3567274463,2903,2231,4441,8455,60812,6737,4268,7235,6154,8698,4157,1669993,4199002,0262588871,5002,2002,2001004001,3002,5003,5004,4005,2006,0006,8000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,645
8,204
7,864
17,394
20,155
18,174
13,300
12,700
4,800
9,800
9,800
8,332
4,153
4,181
3,915
1,860
939
969
535
486
472
504
92
92
159
188
223
3,195
2,724
1,730
515
6,762
6,163
5,792
4,417
0
0
0
0
0
0
0
0
0
0
0
0
330
330
330
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
69,852
78,625
66,218
42,387
19,903
0
0
75,887
93,337
88,447
82,438
72,506
50,380
23,217
12,086
10,989
13,963
12,434
37,932
35,684
30,547
49,042
37,753
44,786
88,282
93,975
74,363
68,219
68,21974,36393,97588,28244,78637,75349,04230,54735,68437,93212,43413,96310,98912,08623,21750,38072,50682,43888,44793,33775,8870019,90342,38766,21878,62569,852000000000000000000000003303303300000000000004,4175,7926,1636,7625151,7302,7243,19522318815992925044724865359699391,8603,9154,1814,1538,3329,8009,8004,80012,70013,30018,17420,15517,3947,8648,2046,64500000000000000000
       Net Receivables 
0
0
0
0
0
0
0
100
0
0
0
0
0
12
32
3
100
212
140
440
447
142
69
327
193
488
669
226
1,273
1,497
1,081
642
1,226
1,189
1,128
819
77
764
810
765
765
4,565
4,641
4,709
359
356
208
861
966
966
105
330
147
130
15
23
36
35
38
40
1,018
46
51
119
333
934
788
481
840
1,231
259
56
74
59
58
3
35
144
330
271
115
244
112
606
124
148
97
111
107
64
47
352
81
38
40
15
0
0
0
7,000
0
0
0
0
3,000
0
2,869
1,047
188
519
5,727
2,209
2,444
2,232
1,640
1,613
1,652
1,617
1,6171,6521,6131,6402,2322,4442,2095,7275191881,0472,86903,00000007,00000015403881352476410711197148124606112244115271330144353585974562591,23184048178893433311951461,0184038353623151301473301059669668612083563594,7094,6414,565765765810764778191,1281,1891,2266421,0811,4971,2732266694881933276914244744014021210033212000001000000000
       Other Current Assets 
0
100
100
100
200
200
100
200
0
100
0
0
0
45
128
31
100
4,400
4,386
11,898
133
114
68
89
611
834
581
782
852
630
591
600
898
1,088
938
774
697
957
827
645
645
139
81
54
283
357
517
530
410
142
165
110
175
124
56
45
42
50
52
29
70
49
75
27
369
373
374
28
251
242
292
89
77
82
90
76
0
98
222
137
315
201
206
156
155
463
867
1,762
2,735
2,092
1,937
1,975
3,802
3,372
2,343
1,654
3,132
2,716
924
689
2,708
1,826
1,321
907
8,268
7,889
7,331
6,283
424
1,961
1,539
1,301
1,067
2,149
1,556
1,343
1,481
2,349
2,3491,4811,3431,5562,1491,0671,3011,5391,9614246,2837,3317,8898,2689071,3211,8262,7086899242,7163,1321,6542,3433,3723,8021,9751,9372,0922,7351,7628674631551562062013151372229807690827789292242251283743733692775497029525042455612417511016514241053051735728354811396456458279576977749381,088898600591630852782581834611896811413311,8984,3864,400100311284500010002001002002001001001000
   > Long-term Assets 
0
300
300
300
300
200
400
800
0
900
800
800
900
763
717
3,307
3,500
3,553
3,466
4,270
0
3,995
3,880
4,014
0
6,228
6,224
7,378
7,125
7,002
6,992
7,081
6,992
6,816
6,509
6,891
7,930
6,567
6,242
5,887
5,887
2,248
1,917
1,605
1,395
1,080
1,009
933
852
821
762
696
1,172
1,164
1,049
965
898
832
777
714
650
607
593
534
472
427
406
383
49
48
48
48
38
38
37
36
5,027
4,927
45,963
45,859
39,487
39,580
39,531
41,867
41,637
41,461
37,391
37,336
38,174
41,502
44,871
46,025
85,548
94,415
94,515
93,180
90,992
56,245
55,575
54,805
53,456
52,835
51,795
51,114
23,294
15,968
14,423
13,264
11,115
10,501
9,512
8,823
8,265
8,103
8,099
7,935
8,078
11,243
11,2438,0787,9358,0998,1038,2658,8239,51210,50111,11513,26414,42315,96823,29451,11451,79552,83553,45654,80555,57556,24590,99293,18094,51594,41585,54846,02544,87141,50238,17437,33637,39141,46141,63741,86739,53139,58039,48745,85945,9634,9275,02736373838484848493834064274725345936076507147778328989651,0491,1641,1726967628218529331,0091,0801,3951,6051,9172,2485,8875,8876,2426,5677,9306,8916,5096,8166,9927,0816,9927,0027,1257,3786,2246,22804,0143,8803,99504,2703,4663,5533,5003,30771776390080080090008004002003003003003000
       Property Plant Equipment 
400
400
300
300
300
300
300
300
400
400
300
300
200
192
159
136
100
122
123
107
116
109
128
398
477
594
730
763
742
798
968
941
1,004
1,009
981
1,090
464
982
930
864
864
278
258
236
212
207
190
156
130
142
124
100
95
83
70
59
50
42
44
38
32
46
57
55
51
59
53
46
7
6
6
6
6
6
5
4
4
11
66
87
350
548
639
748
721
748
709
730
1,374
4,789
8,007
9,245
9,443
19,105
22,136
22,100
21,204
20,667
20,179
19,390
18,354
17,742
16,729
16,076
21,742
15,948
14,403
13,244
11,072
10,402
9,404
8,684
7,988
7,989
7,999
7,847
7,982
11,186
11,1867,9827,8477,9997,9897,9888,6849,40410,40211,07213,24414,40315,94821,74216,07616,72917,74218,35419,39020,17920,66721,20422,10022,13619,1059,4439,2458,0074,7891,374730709748721748639548350876611445666667465359515557463238444250597083951001241421301561902072122362582788648649309824641,0909811,0091,004941968798742763730594477398128109116107123122100136159192200300300400400300300300300300300400400
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,115
0
0
0
1,868
1,868
1,868
1,868
1,868
1,868
1,868
1,868
1,868
1,868
1,868
1,868
1,868
1,868
1,868
1,868
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
38,955
38,955
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000032,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46638,95538,955000000000000000000000000000000000000001,8681,8681,8681,8681,8681,8681,8681,8681,8681,8681,8681,8681,8681,8681,8681,8680002,11500000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
500
500
500
500
400
400
413
400
3,013
3,300
3,273
3,185
3,097
3,002
2,912
2,823
2,733
2,642
2,614
2,586
5,417
3,440
5,203
5,097
3,125
4,887
4,782
4,677
4,572
3,207
4,212
4,114
4,018
4,018
1,066
1,012
958
903
848
794
752
710
667
626
584
999
962
909
840
787
734
681
627
574
521
468
415
362
313
302
291
0
0
0
0
0
0
0
0
4,991
4,875
6,900
6,755
6,609
6,464
6,318
8,587
8,384
8,181
4,150
4,063
3,977
3,890
3,803
3,717
43,042
41,697
38,765
37,471
36,178
1,968
1,924
1,881
1,500
1,471
1,442
1,413
1,384
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000001,3841,4131,4421,4711,5001,8811,9241,96836,17837,47138,76541,69743,0423,7173,8033,8903,9774,0634,1508,1818,3848,5876,3186,4646,6096,7556,9004,8754,991000000002913023133624154685215746276817347878409099629995846266677107527948489039581,0121,0664,0184,0184,1144,2123,2074,5724,6774,7824,8873,1255,0975,2033,4405,4172,5862,6142,6422,7332,8232,9123,0023,0973,1853,2733,3003,0134004134004005005005005000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,431
3,343
4,163
4,021
3,886
3,752
3,616
4,080
5,634
5,494
6,615
6,383
6,204
6,024
6,140
5,988
5,807
5,528
5,801
5,780
5,585
5,312
5,023
1,754
1,970
1,659
1,369
1,183
873
819
777
722
679
638
596
620
1,081
979
906
848
790
733
676
618
561
536
479
421
368
353
337
42
42
42
42
32
32
32
32
5,023
4,916
45,897
45,772
39,137
39,032
38,892
41,119
40,916
40,713
36,682
36,606
36,800
357
595
597
597
1,147
1,148
1,143
1,144
1,144
1,006
1,068
1,136
1,156
1,158
1,159
1,059
20
20
20
43
0
108
139
0
0
0
0
0
0
0000001391080432020201,0591,1591,1581,1561,1361,0681,0061,1441,1441,1431,1481,14759759759535736,80036,60636,68240,71340,91641,11938,89239,03239,13745,77245,8974,9165,02332323232424242423373533684214795365616186767337908489069791,0816205966386797227778198731,1831,3691,6591,9701,7545,0235,3125,5855,7805,8015,5285,8075,9886,1406,0246,2046,3836,6155,4945,6344,0803,6163,7523,8864,0214,1633,3433,43100000000000000000
> Total Liabilities 
800
800
600
600
900
600
600
500
800
700
600
500
600
664
731
930
1,000
4,409
1,476
15,180
15,522
15,386
15,431
15,809
16,409
17,057
17,206
17,212
18,998
18,619
17,679
16,537
17,636
17,543
17,315
17,462
17,751
20,320
21,513
20,950
20,950
19,548
20,511
21,272
16,313
18,598
19,135
20,691
8,468
8,784
10,994
12,765
15,357
15,594
16,177
18,304
28,572
25,524
21,604
32,732
29,566
29,580
29,004
25,687
21,391
23,359
33,510
47,522
18,806
15,327
14,750
14,256
15,392
15,971
28,642
30,635
11,766
9,958
16,976
16,476
12,334
11,759
12,672
10,329
11,960
9,578
7,581
5,851
8,668
6,454
5,783
10,331
40,354
48,343
52,250
46,720
44,952
42,626
43,324
44,254
48,647
47,042
46,589
39,275
37,218
23,729
24,633
23,348
37,453
34,605
44,205
44,049
49,176
83,709
60,762
74,819
64,900
57,968
57,96864,90074,81960,76283,70949,17644,04944,20534,60537,45323,34824,63323,72937,21839,27546,58947,04248,64744,25443,32442,62644,95246,72052,25048,34340,35410,3315,7836,4548,6685,8517,5819,57811,96010,32912,67211,75912,33416,47616,9769,95811,76630,63528,64215,97115,39214,25614,75015,32718,80647,52233,51023,35921,39125,68729,00429,58029,56632,73221,60425,52428,57218,30416,17715,59415,35712,76510,9948,7848,46820,69119,13518,59816,31321,27220,51119,54820,95020,95021,51320,32017,75117,46217,31517,54317,63616,53717,67918,61918,99817,21217,20617,05716,40915,80915,43115,38615,52215,1801,4764,4091,000930731664600500600700800500600600900600600800800
   > Total Current Liabilities 
600
500
300
400
700
500
400
300
700
600
500
500
500
656
728
930
1,000
4,409
1,476
1,650
1,992
1,856
1,901
1,784
2,411
2,784
2,961
2,996
4,768
4,592
3,670
2,542
3,613
3,658
3,538
11,758
10,553
14,668
15,900
11,398
11,398
11,556
15,011
15,772
10,813
13,098
13,635
15,191
2,058
2,392
3,589
4,979
7,612
6,474
7,144
7,992
8,634
8,549
8,078
14,483
14,257
14,769
12,872
14,267
12,190
12,905
14,046
8,986
6,629
7,745
7,771
8,010
8,961
10,044
11,172
12,616
2,898
1,240
1,920
1,570
1,477
7,644
8,707
6,515
8,296
6,065
4,219
2,639
5,607
6,454
5,783
10,331
20,354
21,416
25,542
20,238
38,701
36,613
37,556
38,737
41,959
40,839
41,867
26,473
16,623
12,337
13,685
12,600
7,779
7,420
9,440
8,412
13,422
11,889
16,843
18,422
16,587
17,983
17,98316,58718,42216,84311,88913,4228,4129,4407,4207,77912,60013,68512,33716,62326,47341,86740,83941,95938,73737,55636,61338,70120,23825,54221,41620,35410,3315,7836,4545,6072,6394,2196,0658,2966,5158,7077,6441,4771,5701,9201,2402,89812,61611,17210,0448,9618,0107,7717,7456,6298,98614,04612,90512,19014,26712,87214,76914,25714,4838,0788,5498,6347,9927,1446,4747,6124,9793,5892,3922,05815,19113,63513,09810,81315,77215,01111,55611,39811,39815,90014,66810,55311,7583,5383,6583,6132,5423,6704,5924,7682,9962,9612,7842,4111,7841,9011,8561,9921,6501,4764,4091,000930728656500500500600700300400500700400300500600
       Short-term Debt 
100
100
0
0
0
0
0
0
0
0
0
0
0
90
73
50
26
6
0
0
0
0
0
105
107
283
285
816
789
541
293
294
338
251
335
8,368
8,341
10,868
10,863
6,838
6,838
7,763
11,791
12,108
8,833
10,794
10,895
11,406
64
64
339
445
825
0
0
0
0
0
0
5,500
5,500
5,500
2,750
5,500
2,750
2,750
2,750
2,750
0
0
0
0
0
0
0
250
400
-602
-602
-602
-602
4,000
4,000
0
0
0
-602
-602
-3,726
-544
0
0
10,000
11,690
11,693
11,696
1,699
1,702
3,464
3,467
2,043
2,265
3,478
1,723
1,818
1,822
1,798
1,810
1,773
1,789
1,597
1,649
998
1,044
4,014
5,501
6,749
8,761
8,7616,7495,5014,0141,0449981,6491,5971,7891,7731,8101,7981,8221,8181,7233,4782,2652,0433,4673,4641,7021,69911,69611,69311,69010,00000-544-3,726-602-6020004,0004,000-602-602-602-60240025000000002,7502,7502,7502,7505,5002,7505,5005,5005,500000000825445339646411,40610,89510,7948,83312,10811,7917,7636,8386,83810,86310,8688,3418,3683352513382942935417898162852831071050000062650739000000000000100100
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
400
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,000
10,000
10,000
0
0
1,758
1,758
330
549
1,758
0
0
0
0
0
0
0
0
0
0
0
2,222
4,444
5,926
8,148
8,1485,9264,4442,222000000000001,7585493301,7581,7580010,00010,00010,00000000000000000004000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
459
558
721
700
830
890
956
1,158
796
615
1,111
1,486
1,433
1,358
1,655
2,469
2,484
1,553
1,209
1,780
1,655
1,194
1,434
1,728
1,800
2,255
2,113
2,113
2,733
1,875
2,034
1,226
1,232
1,350
1,595
1,506
2,077
1,832
2,571
3,287
3,698
3,653
3,692
4,094
3,859
2,988
3,383
2,984
2,892
2,947
1,629
1,713
1,878
2,410
2,347
2,039
2,385
1,305
706
863
1,075
1,340
1,630
1,896
638
1,318
968
875
1,042
2,105
1,913
3,694
1,463
3,617
2,037
1,881
5,910
5,783
10,331
6,122
4,189
7,156
2,714
3,763
1,763
1,979
1,262
4,695
2,476
1,469
1,861
4,325
1,601
1,738
1,748
1,811
2,857
3,477
2,592
1,858
3,362
3,099
2,789
3,441
5,018
5,0183,4412,7893,0993,3621,8582,5923,4772,8571,8111,7481,7381,6014,3251,8611,4692,4764,6951,2621,9791,7633,7632,7147,1564,1896,12210,3315,7835,9101,8812,0373,6171,4633,6941,9132,1051,0428759681,3186381,8961,6301,3401,0758637061,3052,3852,0392,3472,4101,8781,7131,6292,9472,8922,9843,3832,9883,8594,0943,6923,6533,6983,2872,5711,8322,0771,5061,5951,3501,2321,2262,0341,8752,7332,1132,1132,2551,8001,7281,4341,1941,6551,7801,2091,5532,4842,4691,6551,3581,4331,4861,1116157961,1589568908307007215584590000000000000
       Other Current Liabilities 
0
500
300
400
700
500
400
300
0
600
500
500
500
19
9
4
119
2,990
3
36
834
520
756
49
818
570
831
49
311
571
832
51
311
572
832
783
311
572
878
567
567
887
1,172
1,457
581
899
1,217
1,023
420
233
1,615
2,244
3,336
2,515
3,235
3,948
4,193
4,343
4,743
5,253
5,426
6,030
6,828
6,853
7,442
8,038
8,638
3,641
4,343
5,113
5,889
6,727
7,520
8,367
9,230
10,134
602
9,320
15,658
15,508
602
2,000
2,000
4,000
4,000
4,000
602
602
512
544
0
0
3,936
5,241
6,397
5,532
32,943
32,852
31,817
33,712
34,925
35,802
36,624
22,593
10,184
8,914
10,149
9,042
4,195
2,774
4,366
4,171
10,566
7,483
9,730
10,132
6,397
-814
-8146,39710,1329,7307,48310,5664,1714,3662,7744,1959,04210,1498,91410,18422,59336,62435,80234,92533,71231,81732,85232,9435,5326,3975,2413,936005445126026024,0004,0004,0002,0002,00060215,50815,6589,32060210,1349,2308,3677,5206,7275,8895,1134,3433,6418,6388,0387,4426,8536,8286,0305,4265,2534,7434,3434,1933,9483,2352,5153,3362,2441,6152334201,0231,2178995811,4571,1728875675678785723117838325723115183257131149831570818497565208343632,990119491950050050060003004005007004003005000
   > Long-term Liabilities 
0
300
300
200
200
100
200
200
0
100
100
100
100
8
3
0
0
0
0
13,530
0
13,530
13,530
14,025
0
14,273
14,245
14,216
14,230
14,027
14,009
13,995
14,023
13,885
13,777
5,704
7,198
5,652
5,613
9,552
9,552
7,992
5,500
5,500
5,500
5,500
5,500
5,500
6,410
6,392
7,405
7,786
7,745
9,120
9,033
10,312
19,938
16,975
13,526
18,249
15,309
14,811
16,132
11,420
9,201
10,454
19,464
38,536
12,177
7,582
6,979
6,246
6,431
5,927
17,470
18,019
8,868
8,718
15,056
14,906
10,857
4,115
3,965
3,814
3,664
3,513
3,362
3,212
3,061
3,061
0
0
20,000
26,927
26,708
26,482
6,251
6,013
5,768
5,517
6,688
6,203
4,722
12,802
20,595
11,392
10,948
10,748
29,674
27,185
34,765
35,637
35,754
71,820
43,919
56,397
48,313
39,985
39,98548,31356,39743,91971,82035,75435,63734,76527,18529,67410,74810,94811,39220,59512,8024,7226,2036,6885,5175,7686,0136,25126,48226,70826,92720,000003,0613,0613,2123,3623,5133,6643,8143,9654,11510,85714,90615,0568,7188,86818,01917,4705,9276,4316,2466,9797,58212,17738,53619,46410,4549,20111,42016,13214,81115,30918,24913,52616,97519,93810,3129,0339,1207,7457,7867,4056,3926,4105,5005,5005,5005,5005,5005,5007,9929,5529,5525,6135,6527,1985,70413,77713,88514,02313,99514,00914,02714,23014,21614,24514,273014,02513,53013,530013,53000003810010010010002002001002002003003000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,428
1,209
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001,2091,4280000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
303
303
303
346
173
185
201
211
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
910
892
1,905
2,286
2,245
3,620
3,533
4,812
14,438
11,475
8,026
18,249
15,309
14,811
13,382
11,420
9,201
10,454
19,464
38,536
12,177
7,582
6,979
6,246
6,431
5,927
17,470
18,019
8,868
8,718
15,056
14,906
10,857
4,115
3,965
3,814
3,664
3,513
3,362
3,212
3,061
0
0
0
20,000
20,000
20,000
20,000
0
0
0
0
0
0
0
8,360
4,028
4,119
4,211
4,264
23,820
0
30,388
31,594
0
0
0
0
0
0
00000031,59430,388023,8204,2644,2114,1194,0288,360000000020,00020,00020,00020,0000003,0613,2123,3623,5133,6643,8143,9654,11510,85714,90615,0568,7188,86818,01917,4705,9276,4316,2466,9797,58212,17738,53619,46410,4549,20111,42013,38214,81115,30918,2498,02611,47514,4384,8123,5333,6202,2452,2861,9058929100000000000000002112011851733463033033030000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,868
0
0
0
4,266
0
4,266
4,266
3,664
3,664
3,362
3,212
3,061
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000003,0613,2123,3623,6643,6644,2664,26604,2660004,8680000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
6,500
5,900
5,000
4,100
3,300
2,400
1,900
0
300
2,500
2,500
1,800
1,043
404
4,437
3,600
13,820
15,719
16,458
15,004
13,889
12,375
10,644
9,078
7,966
5,676
2,819
489
-1,876
-1,339
-3,508
-5,825
953
-1,515
-3,799
-6,661
-8,559
-12,285
-13,139
-13,139
-8,974
-12,255
-14,199
-9,887
-13,722
-15,501
-17,191
681
-1,432
-4,074
-7,011
-11,186
-11,970
-13,826
-15,599
-26,989
-20,329
-17,979
-30,453
-20,795
-22,704
-23,939
-23,467
-17,606
-20,163
-31,073
-46,288
-17,076
-13,606
-12,353
-13,164
-14,779
-15,493
-28,402
-30,355
4,816
3,159
59,949
73,073
67,721
65,661
61,480
63,485
99,098
95,706
89,078
89,880
170,098
169,199
160,914
150,245
134,045
117,793
107,160
96,052
178,430
132,377
121,054
115,111
102,551
94,390
84,086
79,744
42,368
31,443
20,086
15,413
26,761
18,740
9,345
22,038
14,826
-8,881
73,241
45,773
44,031
41,396
41,39644,03145,77373,241-8,88114,82622,0389,34518,74026,76115,41320,08631,44342,36879,74484,08694,390102,551115,111121,054132,377178,43096,052107,160117,793134,045150,245160,914169,199170,09889,88089,07895,70699,09863,48561,48065,66167,72173,07359,9493,1594,816-30,355-28,402-15,493-14,779-13,164-12,353-13,606-17,076-46,288-31,073-20,163-17,606-23,467-23,939-22,704-20,795-30,453-17,979-20,329-26,989-15,599-13,826-11,970-11,186-7,011-4,074-1,432681-17,191-15,501-13,722-9,887-14,199-12,255-8,974-13,139-13,139-12,285-8,559-6,661-3,799-1,515953-5,825-3,508-1,339-1,8764892,8195,6767,9669,07810,64412,37513,88915,00416,45815,71913,8203,6004,4374041,0431,8002,5002,50030001,9002,4003,3004,1005,0005,9006,5000
   Common Stock
0
1,300
1,300
1,300
1,300
1,300
1,300
1,300
0
1,500
0
0
0
34
34
60
100
115
120
126
132
133
133
133
132
132
132
132
132
132
133
133
134
154
155
155
155
157
157
176
176
35
35
35
35
35
35
36
36
56
56
65
95
113
116
131
132
154
157
159
191
193
194
195
239
241
242
242
247
248
253
255
6
260
265
6
200
200
299
327
328
328
328
338
403
403
403
409
469
472
473
480
479
479
492
511
836
836
848
845
961
990
1,013
1,019
1,472
1,471
1,467
77
177
179
215
247
265
276
417
434
457
490
490457434417276265247215179177771,4671,4711,4721,0191,013990961845848836836511492479479480473472469409403403403338328328328327299200200626526062552532482472422422412391951941931911591571541321311161139565565636363535353535351761761571571551551551541341331331321321321321321321331331331321261201151006034340001,50001,3001,3001,3001,3001,3001,3001,3000
   Retained Earnings Total Equity0000000-721,097-704,4430-694,2100000-601,913-586,706-570,704-554,876-547,639-534,629-486,470-470,039-452,667-428,743-410,188-392,711-376,292-364,592-359,792-351,342-345,999-337,720-332,473-325,471-322,847-316,144-310,600-308,260-302,187-298,074-296,074-283,447-281,238-267,274-266,421000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
-200
-200
-200
-300
-300
-300
-300
-400
-600
-700
-700
-700
-800
-815
-848
-880
-908
-932
-956
-977
-972
-1,045
-1,045
-1,045
-992
-1,380
-1,362
-1,361
-1,336
-1,430
-1,398
-1,391
-1,325
-1,422
-1,416
-1,391
-1,357
-1,333
-1,273
-1,224
-1,224
-1,045
-1,045
-1,045
-1,045
-1,045
-1,045
-1,045
-1,045
-1,045
-1,045
-1,045
-1,000,000,000,000,000
-877
0
-1,000,000,000,000,000
-1,361
-1,000,000,000,000,000
-1,000,000,000,000,000
-1,000,000,000,000,000
-870
-1,000,000,000,000,000
-1,000,000,000,000,000
-17,750,006,310,000
-834
-1,000,000,000,000,000
-1,000,000,000,000,000
-1,000,000,000,000,000
-891
-1,000,000,000,000,000
-1,000,000,000,000,000
-1,000,000,000,000,000
0
-1,000,000,000,000,000
-1,000,000,000,000,000
-1,000,000,000,000,000
-10
-10
0
0
-31
-31
0
0
-179
-179
0
0
-386
-386
0
0
-1,560
-1,560
0
0
-4,157
386
133
17
-10
3
-1
-9
-27
-30
-34
-44
-129
-65
-95
-99
-66
-184
-134
-84
8
-67
-678-84-134-184-66-99-95-65-129-44-34-30-27-9-13-1017133386-4,15700-1,560-1,56000-386-38600-179-17900-31-3100-10-10-1,000,000,000,000,000-1,000,000,000,000,000-1,000,000,000,000,0000-1,000,000,000,000,000-1,000,000,000,000,000-1,000,000,000,000,000-891-1,000,000,000,000,000-1,000,000,000,000,000-1,000,000,000,000,000-834-17,750,006,310,000-1,000,000,000,000,000-1,000,000,000,000,000-870-1,000,000,000,000,000-1,000,000,000,000,000-1,000,000,000,000,000-1,361-1,000,000,000,000,0000-877-1,000,000,000,000,000-1,045-1,045-1,045-1,045-1,045-1,045-1,045-1,045-1,045-1,045-1,045-1,224-1,224-1,273-1,333-1,357-1,391-1,416-1,422-1,325-1,391-1,398-1,430-1,336-1,361-1,362-1,380-992-1,045-1,045-1,045-972-977-956-932-908-880-848-815-800-700-700-700-600-400-300-300-300-300-200-200-200
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
231,049
231,617
0
0
0
0
0
0
0
0
251,389
251,525
252,575
253,090
300,690
301,033
361,837
381,006
377,993
381,477
383,999
388,618
431,168
433,023
434,674
440,813
529,421
533,319
536,733
542,476
543,754
546,057
559,335
565,580
664,064
665,784
667,712
669,125
672,304
680,103
684,987
0
0
0
0
709,590
0
723,069
730,322
0
0
0
0
0
0
0
0000000730,322723,0690709,5900000684,987680,103672,304669,125667,712665,784664,064565,580559,335546,057543,754542,476536,733533,319529,421440,813434,674433,023431,168388,618383,999381,477377,993381,006361,837301,033300,690253,090252,575251,525251,38900000000231,617231,04900000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-20000000000000000000
   Other Stockholders Equity 
0
17,900
18,000
18,000
18,400
18,400
18,400
19,100
0
20,100
24,800
25,600
25,700
24,909
25,202
29,920
30,000
41,238
44,578
46,621
0
47,853
47,856
47,869
0
48,988
48,988
48,988
48,985
49,125
49,313
49,343
49,593
58,802
58,880
58,999
59,006
59,504
59,504
60,645
60,645
63,057
63,107
63,178
68,795
69,087
69,417
69,683
116,014
126,309
126,427
126,810
224,704
226,536
227,284
230,057
214,686
220,677
221,680
222,375
230,149
230,575
231,045
231,613
237,596
240,369
240,497
240,593
250,649
250,764
251,145
251,231
251,636
252,252
252,571
253,086
300,690
301,033
361,837
381,006
377,993
381,477
383,999
388,618
431,168
433,023
434,674
440,813
529,421
533,319
536,733
542,476
543,754
546,057
559,335
565,580
664,064
665,784
667,712
669,125
672,304
680,103
684,987
687,691
696,563
706,433
703,379
709,590
722,049
723,069
730,322
754,823
764,151
772,129
846,654
849,388
856,824
866,260
866,260856,824849,388846,654772,129764,151754,823730,322723,069722,049709,590703,379706,433696,563687,691684,987680,103672,304669,125667,712665,784664,064565,580559,335546,057543,754542,476536,733533,319529,421440,813434,674433,023431,168388,618383,999381,477377,993381,006361,837301,033300,690253,086252,571252,252251,636251,231251,145250,764250,649240,593240,497240,369237,596231,613231,045230,575230,149222,375221,680220,677214,686230,057227,284226,536224,704126,810126,427126,309116,01469,68369,41769,08768,79563,17863,10763,05760,64560,64559,50459,50459,00658,99958,88058,80249,59349,34349,31349,12548,98548,98848,98848,988047,86947,85647,853046,62144,57841,23830,00029,92025,20224,90925,70025,60024,80020,100019,10018,40018,40018,40018,00018,00017,9000



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-2,907
Gross Profit-2,907-2,907
 
Operating Income (+$)
Gross Profit-2,907
Operating Expense-61,304
Operating Income-64,211-64,211
 
Operating Expense (+$)
Research Development34,360
Selling General Administrative29,851
Selling And Marketing Expenses0
Operating Expense61,30464,211
 
Net Interest Income (+$)
Interest Income4,246
Interest Expense-4,208
Other Finance Cost-0
Net Interest Income38
 
Pretax Income (+$)
Operating Income-64,211
Net Interest Income38
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-63,734-64,688
EBIT - interestExpense = -71,326
-63,734
-59,526
Interest Expense4,208
Earnings Before Interest and Taxes (EBIT)-67,118-59,526
Earnings Before Interest and Taxes (EBITDA)-64,211
 
After tax Income (+$)
Income Before Tax-63,734
Tax Provision-0
Net Income From Continuing Ops-63,734-63,734
Net Income-63,734
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses64,211
Total Other Income/Expenses Net477-38
 

Technical Analysis of Abeona Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Abeona Therapeutics Inc. The general trend of Abeona Therapeutics Inc is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Abeona Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Abeona Therapeutics Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Abeona Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 5.93 < 6.11 < 6.84.

The bearish price targets are: 5.49 > 5.12 > 4.87.

Know someone who trades $ABEO? Share this with them.πŸ‘‡

Abeona Therapeutics Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Abeona Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Abeona Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Abeona Therapeutics Inc. The current macd is -0.05955248.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Abeona Therapeutics Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Abeona Therapeutics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Abeona Therapeutics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Abeona Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartAbeona Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Abeona Therapeutics Inc. The current adx is 11.39.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Abeona Therapeutics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Abeona Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Abeona Therapeutics Inc. The current sar is 6.01203234.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Abeona Therapeutics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Abeona Therapeutics Inc. The current rsi is 50.40. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Abeona Therapeutics Inc Daily Relative Strength Index (RSI) ChartAbeona Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Abeona Therapeutics Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Abeona Therapeutics Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Abeona Therapeutics Inc Daily Stochastic Oscillator ChartAbeona Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Abeona Therapeutics Inc. The current cci is -2.78320945.

Abeona Therapeutics Inc Daily Commodity Channel Index (CCI) ChartAbeona Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Abeona Therapeutics Inc. The current cmo is 5.30586375.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Abeona Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartAbeona Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Abeona Therapeutics Inc. The current willr is -30.64516129.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Abeona Therapeutics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Abeona Therapeutics Inc Daily Williams %R ChartAbeona Therapeutics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Abeona Therapeutics Inc.

Abeona Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Abeona Therapeutics Inc. The current atr is 0.27768169.

Abeona Therapeutics Inc Daily Average True Range (ATR) ChartAbeona Therapeutics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Abeona Therapeutics Inc. The current obv is 10,468,048.

Abeona Therapeutics Inc Daily On-Balance Volume (OBV) ChartAbeona Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Abeona Therapeutics Inc. The current mfi is 40.46.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Abeona Therapeutics Inc Daily Money Flow Index (MFI) ChartAbeona Therapeutics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Abeona Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-31STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-01ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-11ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-05-06ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-07-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Abeona Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Abeona Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.397
Ma 20Greater thanMa 505.863
Ma 50Greater thanMa 1006.033
Ma 100Greater thanMa 2005.574
OpenGreater thanClose5.710
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Abeona Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Abeona Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Abeona Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Abeona Therapeutics Inc

I send you an email if I find something interesting about Abeona Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Abeona Therapeutics Inc.

Receive notifications about Abeona Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.